Kevin Doe's Album: Wall Photos
The blood-brain
barrier (BBB) penetrating drugs market is estimated to be worth USD 900
million in 2030. (predicts Roots Analysis)
Advances in biotechnology have enabled the development of
versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ
(brain perfusion) blood–brain barrier models, allowing more effective and safe
delivery of drugs across brain capillaries
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd
Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology
Platforms and Therapeutics.”
The
report features an extensive study of the current market landscape, offering an
informed opinion on the likely adoption of BBB penetration technologies and
affiliated drugs, over the next decade. The report features an in-depth
analysis, highlighting the diverse capabilities of stakeholders engaged in this
domain. In addition to other elements, the study includes:
To request for sample report, click here - https://www.rootsanalysis.com/reports/310/request-sample.html
§ An
overview of the overall landscape of BBB penetration technologies, featuring an
in-depth analysis of the technologies based on a number of parameters
§ A
detailed assessment of the current market landscape of BBB penetrant drugs.
§ Identification
of contemporary market trends, depicted using three schematic representations,
which include [A] a tree map representation, [B] a bubble analysis and [C] an
informative heptagon representation.
§ An
insightful competitiveness analysis of BBB penetration technologies, taking
into consideration the supplier power and key technology specific information.
§ Elaborate
profiles of prominent technology developers that are engaged in the development
of at least four drugs.
§ An
analysis of the partnerships that have been established in the domain, in the
period between 2014 and 2020.
§ An
elaborate discussion on the deal structures of various types of technology
licensing agreements inked in this domain.
§ An
analysis of the investments made in the domain, in the period between 2014 and
2020 (till March).
§ An
in-depth analysis of the various patents that have been filed / granted related
to BBB penetration technologies, till November 2019.
§ An
insightful chessboard analysis highlighting the most preferred / popular drug
development strategies / paths adopted by majority of the drug developers (with
clinical candidates) in order to progress their lead drug candidates.
§ An
assessment of the most commonly targeted disorders affecting the CNS, shortlisted
on the basis of number of BBB penetrant drugs in development.
§ A
list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s
disease that are likely to partner with BBB penetration technology providers.
§ A
case study highlighting the working principle of the most common approaches
that are being employed for the development of BBB penetration technologies.
§ An
informative analysis of contemporary Google Trends in the time period between
2015 and 2019 (till December) and insights generated from recent news articles
related to the BBB, indicating the increasing popularity of this domain.
A detailed market forecast, featuring analysis
of the current and projected future opportunity across key market segments
(listed below) :
§ Type
of Payment Model Adopted
§ Upfront
payments
§ Milestone
payments
§ Type
of Molecule
§ Small
Molecules
§ Biologics
§ Target
Disease Indication
§ Brain
Metastases in Breast Cancer
§ Glioblastoma
Multiforme
§ Hunter
Syndrome
§ Hurler
Syndrome
§ Leading
Technology Platforms
§ G®-Technology
§ J-Brain
Cargo® Technology
§ LRP-1
Technology
§ Trojan
Horse Technology
§ Leading
Drug Developers
§ 2-BBB
§ Angiochem
§ ArmaGen
§ JCR
Pharmaceuticals
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia-Pacific
Key
companies covered in the report
§ Angiochem
§ ArmaGen
§ BioArctic
§ Cyclenium
Pharma
§ Denali
Therapeutics
§ ICB
International
§ Iproteos
§ JCR
Pharmaceuticals
§ Lauren
Sciences
§ Medesis
Pharma
§ Ossianix
§ Vect-Horus
For additional
details, please visit
https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html or
email sales@rootsanalysis.com
You may also be
interested in the following titles:
1.
Novel Coronavirus
(Covid-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
2.
DNA-Encoded Libraries:
Platforms and Services Market
3.
Global Stem Cells
Market: Focus on Clinical Therapies, 2020–2030
About Roots Analysis
Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at
info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav
Chaudhary
ben.johnson@rootsanalysis.com
Facebook
- https://www.facebook.com/RootsAnalysis
LinkedIn
- https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter
- https://twitter.com/RootsAnalysis
barrier (BBB) penetrating drugs market is estimated to be worth USD 900
million in 2030. (predicts Roots Analysis)
Advances in biotechnology have enabled the development of
versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ
(brain perfusion) blood–brain barrier models, allowing more effective and safe
delivery of drugs across brain capillaries
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd
Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology
Platforms and Therapeutics.”
The
report features an extensive study of the current market landscape, offering an
informed opinion on the likely adoption of BBB penetration technologies and
affiliated drugs, over the next decade. The report features an in-depth
analysis, highlighting the diverse capabilities of stakeholders engaged in this
domain. In addition to other elements, the study includes:
To request for sample report, click here - https://www.rootsanalysis.com/reports/310/request-sample.html
§ An
overview of the overall landscape of BBB penetration technologies, featuring an
in-depth analysis of the technologies based on a number of parameters
§ A
detailed assessment of the current market landscape of BBB penetrant drugs.
§ Identification
of contemporary market trends, depicted using three schematic representations,
which include [A] a tree map representation, [B] a bubble analysis and [C] an
informative heptagon representation.
§ An
insightful competitiveness analysis of BBB penetration technologies, taking
into consideration the supplier power and key technology specific information.
§ Elaborate
profiles of prominent technology developers that are engaged in the development
of at least four drugs.
§ An
analysis of the partnerships that have been established in the domain, in the
period between 2014 and 2020.
§ An
elaborate discussion on the deal structures of various types of technology
licensing agreements inked in this domain.
§ An
analysis of the investments made in the domain, in the period between 2014 and
2020 (till March).
§ An
in-depth analysis of the various patents that have been filed / granted related
to BBB penetration technologies, till November 2019.
§ An
insightful chessboard analysis highlighting the most preferred / popular drug
development strategies / paths adopted by majority of the drug developers (with
clinical candidates) in order to progress their lead drug candidates.
§ An
assessment of the most commonly targeted disorders affecting the CNS, shortlisted
on the basis of number of BBB penetrant drugs in development.
§ A
list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s
disease that are likely to partner with BBB penetration technology providers.
§ A
case study highlighting the working principle of the most common approaches
that are being employed for the development of BBB penetration technologies.
§ An
informative analysis of contemporary Google Trends in the time period between
2015 and 2019 (till December) and insights generated from recent news articles
related to the BBB, indicating the increasing popularity of this domain.
A detailed market forecast, featuring analysis
of the current and projected future opportunity across key market segments
(listed below) :
§ Type
of Payment Model Adopted
§ Upfront
payments
§ Milestone
payments
§ Type
of Molecule
§ Small
Molecules
§ Biologics
§ Target
Disease Indication
§ Brain
Metastases in Breast Cancer
§ Glioblastoma
Multiforme
§ Hunter
Syndrome
§ Hurler
Syndrome
§ Leading
Technology Platforms
§ G®-Technology
§ J-Brain
Cargo® Technology
§ LRP-1
Technology
§ Trojan
Horse Technology
§ Leading
Drug Developers
§ 2-BBB
§ Angiochem
§ ArmaGen
§ JCR
Pharmaceuticals
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia-Pacific
Key
companies covered in the report
§ Angiochem
§ ArmaGen
§ BioArctic
§ Cyclenium
Pharma
§ Denali
Therapeutics
§ ICB
International
§ Iproteos
§ JCR
Pharmaceuticals
§ Lauren
Sciences
§ Medesis
Pharma
§ Ossianix
§ Vect-Horus
For additional
details, please visit
https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html or
email sales@rootsanalysis.com
You may also be
interested in the following titles:
1.
Novel Coronavirus
(Covid-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
2.
DNA-Encoded Libraries:
Platforms and Services Market
3.
Global Stem Cells
Market: Focus on Clinical Therapies, 2020–2030
About Roots Analysis
Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at
info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav
Chaudhary
ben.johnson@rootsanalysis.com
- https://www.facebook.com/RootsAnalysis
- https://www.linkedin.com/company/roots-analysis/mycompany/
- https://twitter.com/RootsAnalysis